Antigen- Specific Immune Tolerance Drug Development Summit

Start Date : April 24, 2018
End Date : April 26, 2018
Time : 8:00 am to5:00 pm

Phone : +6174554188
Email :

Location :
The Aloft Boston Seaport, 401-403 D St, 02210, Boston, MA, United States



As the first generation of antigen-specific immune tolerance therapies enter clinics and with excitement around recent partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to be able to meet and share knowledge.


The 1st Antigen-Specific Immune Tolerance Drug Development Summit is that forum, and has a brand-new agenda that can help you successfully overcome the scientific, product development and commercialization challenges currently being faced.





Conference + 2 Workshops Earlybird (Book by 26/01/18): USD 3197

Conference + 2 Workshops (standard rate): USD 3797

Conference + 1 Workshop Earlybird (Book by 26/01/18): USD 2798

Conference + 1 Workshop (standard rate): USD 3398

Conference Earlybird (Book by 26/01/18): USD 2199

Conference (Standard rate): USD 2799

Speakers: Amy S. Rosenberg (CDER/FDA), Arpita Maiti (Pfizer, Inc.), Lachy McLean (Takeda Pharmaceuticals), Jose M. Carballido (Novartis), Jack A. Ragheb (Eli Lilly & Co), Lawrence A. Steinman (Tolerion), Laurence A. Turka (Immune Tolerance Network), Matthias von Herrath (Novo Nordisk), Kei Kishimoto (Selecta Biosciences), Jonathan Zalevsky (Nektar Therapeutics), Francisco J. Quintana (AnTolRx)

Registration Info

Register Now


Organized by

Organized by LoveEvvnt1

Hanson Wade

Event Categories: Health & Nutrition.

Your Review

You must be logged in to post a comment.